Regenerative Medicine and Stem Cells Technologies

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

• Feb 27 2022 - 14:56

Researchers identify biomarkers to predict patient response to immunotherapy treatment for melanoma

• Feb 27 2022 - 14:48

Scientists develop a new platform technology for personalized cancer therapy

• Feb 26 2022 - 15:15

FDA clears IND application for CAR-natural killer cell therapy to treat B-cell malignancies

• Feb 26 2022 - 11:07

The influence of CD26+ and CD26− fibroblasts on the regeneration of human dermo-epidermal skin substitutes

• Feb 23 2022 - 14:15

CXCL10: a promising marker for immunotherapy response in metastatic melanoma

• Feb 21 2022 - 15:15

Optimization of Mechanical Tissue Dissociation Using an Integrated Microfluidic Device for Improved Generation of Single Cells Following Digestion

• Feb 21 2022 - 13:12

Stem cell rejuvenation helps immunotherapy fight cancer tirelessly

• Feb 20 2022 - 15:42

Immunotherapy is a promising new form of cancer treatment, but the supercharged immune cells it employs can become exhausted in the fight. Researchers in Japan have found a way to keep them going for longer, by rejuvenating them with stem cells.

Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs

• Feb 20 2022 - 09:01

Specific cancer driving protein plays important role in lung cancer development

• Feb 19 2022 - 09:20